期刊文献+

急性冠脉综合征患者氨基末端脑钠肽前体水平检测及临床意义分析 被引量:18

Study on Detection and Clinical Significance of the Plasma Level of NT-proBNP in Patients with Acute Coronary Syndrome
下载PDF
导出
摘要 目的探讨急性冠脉综合征(ACS)患者血浆氨基末端脑钠肽前体(NT-proBNP)水平及其临床意义。方法选取临床上诊断为ACS的患者322例,其中急性心肌梗死(AM I)患者207例(AM I组包括ST段抬高性心肌梗死和非ST段抬高性心肌梗死),不稳定心绞痛(UA)患者115例(UA组);同时选取冠状动脉造影正常者45例作为正常对照组。检测血浆NT-proBNP及肌钙蛋白T(cTnT)、超敏C反应蛋白(hs-CRP)水平。彩色超声心动图检测其左室射血分数(LVEF)。结果 (1)AM I组NT-proBNP水平为897.6[219.4~1918.5]pg/m l,明显高于UA组的182.1[84.9~596.2]pg/m l,且两组患者NT-proBNP水平均明显高于正常对照组的117.7[66.6~213.2]pg/m l,差异均有统计学意义(P<0.05)。(2)NT-proBNP与hs-CRP、cTnT呈正相关(r=0.451,P=0.000;r=0.183,P=0.001),与LVEF呈负相关(r=-0.423,P=0.000)。(3)不同冠状动脉病变程度者NT-proBNP水平间差异有统计学意义(P<0.001)。结论 NT-proBNP可以作为心肌缺血范围和严重程度以及左心室功能受损的指标,测定ACS患者的NT-proBNP水平,有助于对该类患者进行早期危险分层,指导临床治疗方案的制定。 Objective To discuss the plasma level and clinical significance of NT-proBNP in Patients with Acute Coronary Syndrome(ACS).Methods 322 patients with ACS were selected,among which 207 cases in acute myocardial infarction(AMI) group(including ST elevation myocardial infarction and non-ST elevation myocardial infarction),115 cases in unstable angina pectoris(UAP) group,and 45 cases in normal control group.Plasma level of NT-proBNP,cTnT and hs-CRP were detected,and LVEF was tested by ultrasonic cardiography.Results ①AMI patients had significantly higher NT-proBNP levels(897.6[219.4~1918.5]pg/ml) than UAP group(182.1[84.9~596.2])(P0.05).Both of the two groups had significantly higher NT-proBNP levels than normal control group(117.7[66.6~213.2]pg/ml)(P0.05).② The plasma level of NT-proBNP was positively correlated with hs-CRP(r=0.451,P=0.000)and cTnT(r=0.183,P=0.001),and negatively correlated with LVEF(r=-0.423,P=0.000).③ The plasma level of NT-proBNP was significantly positively correlated with the lesion of coronary artery(P0.001).Conclusion NT-proBNP can be an index judging the range and severity of ischemia myocardial and impaired left ventricle.Detecting plasma level of NT-proBNP in ACS patients can be beneficial in the early risk stratification and clinical therapy.
出处 《中国全科医学》 CAS CSCD 北大核心 2011年第17期1905-1907,共3页 Chinese General Practice
关键词 急性冠脉综合征 氨基末端脑钠肽前体 超声心动描记术 Acute coronary syndrome NT-proBNP Echocardiography
  • 相关文献

参考文献11

  • 1张玉莉.老年心力衰竭患者B型脑钠肽水平与心肌功能指数的关系[J].中国基层医药,2009,16(5):787-788. 被引量:29
  • 2Talwar S,Squire IB,Downie PF,et al.Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina[J].Heart,2000,84(4):421-424.
  • 3Stein BC,Levin RI.Natriuretic peptides:physiology,therapeutic potential,and risk stratification in ischemic heart disease[J].Am Heart J,1998,135(5 Pt 1):914-923.
  • 4Sun T,Wang L,Zhang Y.Prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes[J].Arch Med Res,2006,37(4):502-505.
  • 5Choi EY,Kwon HM,Yoon YW,et al.Assessment of extent of myocardial ischemia in patients with non-ST elevation acute coronary syndrome using serum B-type natriuretic peptide level[J].Yonsei Med J,2004,45(2):255-262.
  • 6De Lemos JA,Morrow DA,Bentley JH,et al.The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes[J].N Engl J Med,2001,345(14):1014-1021.
  • 7Talwar S,Squire IB,Downie PF,et al.Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina[J].Heart,2000.84(4):421-424.
  • 8Struthers AD,Davies J.B-type natriuretic peptide:a simple new test to identify coronary artery disease?[J].QJM,2005,98(10):765-769.
  • 9Weber M,Dill T,Arnold R,et al.N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris[J].Am Heart J,2004,148(4):612-620.
  • 10南静,董玉华,邱明生.脑钠肽与心力衰竭相关性研究[J].中国基层医药,2009,16(11):2008-2008. 被引量:11

二级参考文献16

  • 1戴华,莫艳波,肖文良,张小梅,武彩娥.B型利钠肽和左室舒张功能障碍关系的研究[J].中国医师进修杂志(内科版),2006,29(3):29-30. 被引量:6
  • 2王邦宁,张凤祥,陈大年,骆志刚,黄其植.生理性起搏与非生理性起搏对血浆心房利钠肽脑钠肽水平的影响[J].中国临床保健杂志,2006,9(6):554-555. 被引量:5
  • 3Wiese S,Breyer T,Dragu A,et al.Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium:influence of angiotensin Ⅱ and diastolic fiber length.Circulation,2000,102 (25):3074-3079.
  • 4Tei C,Nishimura RA,Seward JB,et al.Noninvasive Doppler-derived myocardial performance index:correlation with simultaneous measurements of cardiac catheterization measurements.J Am Soc Echocardiogr,1997,10 (2):169-178.
  • 5陈灏珠.心脏病学.5版.北京:人民卫生出版社,2001:407.
  • 6Sudoh T,Kangawa K,Minamino N,et al.A new natriuretic peptide in porcine brain.Nature,1988,322(6159):78-81.
  • 7Boomsma F,Van Den Meiracker AH.Plasma A-and B-typo natriuretic peptides:physiology,methodology and clinical use.Cardiovasc Res,2001,51 (3):442-449.
  • 8De Denus S,Pharand C,Williamson DR.Brain natriuretic peptide in the management of heart failure:the versatile neurohormone.Chest,2004,125 (2):652-668.
  • 9Levin ER,Gardner DG,Samson WK.Natriuretic peptides.N Ensl J Med,1998,339(5):321-328.
  • 10刘雅,肖茜,王超.脑钠肽的研究现状和进展[J].陕西医学杂志,2008,37(1):116-118. 被引量:25

共引文献33

同被引文献195

引证文献18

二级引证文献125

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部